Octreotide Stocks List
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
VTI | B | Vanguard Total Stock Market ETF | 0.0 | |
VXF | C | Vanguard Extended Market ETF | 0.0 |
Compare ETFs
Date | Stock | Title |
---|---|---|
May 14 | RANI | Rani Therapeutics to Participate in May Investor Conferences |
Related Industries:
Biotechnology
- Octreotide
Octreotide, sold under the brand name Sandostatin among others, is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer, and binds predominantly to the somatostatin receptors SSTR2 and SSTR5. It was approved for use in the United States in 1988.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles